[1]
Aghemo, A., Lunghi, G., Ravasio, R., Torresani, E., Dionisi, M., Paolini, D. and Colombo, M. 2016. Cost analysis of residual viremia detected by two real-time PCR assays for response-guided (dual or triple) therapy of HCV genotype 1 infection: Analisi Economica Associata all’utilizzo Di Due Test (Real-Time PCR-Based) per Valutare La Determinazione Dell’HCV-RNA Nei Pazienti HCV Genotipo 1 in Trattamento Con Duplice o Triplice Terapia. Global and Regional Health Technology Assessment. 4, 1 (Jan. 2016), 22–27. DOI:https://doi.org/10.33393/grhta.2017.371.